Literature DB >> 12975030

Nutrition therapy for dyslipidemia.

Jo Ann S Carson1.   

Abstract

National guidelines indicate patients with elevated low- density lipoprotein cholesterol should consume less than 7% of calories from saturated fat and less than 200 mg of cholesterol. Trans fatty acids should also be limited. Incorporation of functional foods, such as stanol-containing margarine, soy products, and soluble fiber-rich cereals and vegetables can provide further benefit. In addition to weight loss and physical activity, individuals with hypertriglyceridemia benefit from a diet moderate in fat and carbohydrate rather than a low-fat diet. Including monounsaturated or omega-3 fatty acids lowers serum triglycerides. Many of the dietary strategies to optimize serum lipids also contribute to glycemic control in patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12975030     DOI: 10.1007/s11892-003-0084-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   5.430


  45 in total

1.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

Authors:  Penny M Kris-Etherton; William S Harris; Lawrence J Appel
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

2.  Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications.

Authors:  Marion J Franz; John P Bantle; Christine A Beebe; John D Brunzell; Jean-Louis Chiasson; Abhimanyu Garg; Lea Ann Holzmeister; Byron Hoogwerf; Elizabeth Mayer-Davis; Arshag D Mooradian; Jonathan Q Purnell; Madelyn Wheeler
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

3.  A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia.

Authors:  David J A Jenkins; Cyril W C Kendall; Dorothea Faulkner; Edward Vidgen; Elke A Trautwein; Tina L Parker; Augustine Marchie; George Koumbridis; Karen G Lapsley; Robert G Josse; Lawrence A Leiter; Philip W Connelly
Journal:  Metabolism       Date:  2002-12       Impact factor: 8.694

4.  Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus.

Authors:  M Chandalia; A Garg; D Lutjohann; K von Bergmann; S M Grundy; L J Brinkley
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

5.  Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis.

Authors:  S Yu-Poth; G Zhao; T Etherton; M Naglak; S Jonnalagadda; P M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  1999-04       Impact factor: 7.045

6.  Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels.

Authors:  A H Lichtenstein; L M Ausman; S M Jalbert; E J Schaefer
Journal:  N Engl J Med       Date:  1999-06-24       Impact factor: 91.245

7.  Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes.

Authors:  L K Heilbronn; M Noakes; P M Clifton
Journal:  Diabetes Care       Date:  1999-06       Impact factor: 19.112

8.  Blood levels of long-chain n-3 fatty acids and the risk of sudden death.

Authors:  Christine M Albert; Hannia Campos; Meir J Stampfer; Paul M Ridker; JoAnn E Manson; Walter C Willett; Jing Ma
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

9.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

Review 10.  Recent discoveries in inclusive food-based approaches and dietary patterns for reduction in risk for cardiovascular disease.

Authors:  Penny M Kris-Etherton; Terry D Etherton; Joseph Carlson; Christopher Gardner
Journal:  Curr Opin Lipidol       Date:  2002-08       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.